$ATOS
Atossa Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.29
▼-4.58%-$0.110
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAtossa Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ATOS down today? It is at $2.29 (-4.58%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ATOS spikes, and full due diligence on ATOS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ATOS 1 time in the last 30 days. Create a free account to track $ATOS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ATOS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ATOS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cigler Tessa Director | Acquired (grant/award) | +10K 0.1% of company | n/a | 10K | n/a | May 12, 26 |
Galli Stephen J Director | Acquired (grant/award) | +10K 0.1% of company | added 100% | 10K | n/a | May 12, 26 |
Finn Jonathan Director | Acquired (grant/award) | +10K 0.1% of company | added 100% | 12K | n/a | May 12, 26 |
Remmel H. Lawrence Director | Acquired (grant/award) | +10K 0.1% of company | added 100% | 11K | n/a | May 12, 26 |
Chen Shu-Chih Director | Acquired (grant/award) | +10K 0.1% of company | n/a | 10K | n/a | May 12, 26 |
Steinhart Richard I Director | Acquired (grant/award) | +10K 0.1% of company | n/a | 10K | n/a | May 12, 26 |
Quay Steven C Officer | Acquired (grant/award) | +65K 0.7% of company | added 100% | 88K | n/a | Mar 27, 26 |
Daniel Mark James Officer | Acquired (grant/award) | +63K 0.6% of company | n/a | 63K | n/a | Mar 26, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ATOS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ATOS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ATOS last traded at $2.29, down 4.58% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Atossa Therapeutics, Inc. Common Stock (ATOS) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ATOS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ATOS 1 time in the last 30 days.
ATOS (Atossa Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $22M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ATOS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ATOS discussion
Sign in to ask a question or join the discussion.